2
1 2 3 4 OMEGA AU 0 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min App ID 23737 TMS TMS + + OMEGA OMEGA OMEGA OMEGA USP:L1 AU AU 0 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min Adenine G-5-MP Thymine 100% 80% 60% 40% 20% 0% App ID 23577 Comparative separations may not be representative of all applications. Comparative separations may not be representative of all applications. min 0 1 1 2 2 3 4 5 4 0 200 400 600 800 1000 1200 1400 0 1 1 2 2 3 4 4 5 min 0 250 500 750 1000 App ID 24612 App ID 24613 App ID 23727 3 1 2 3 4 5 3 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min AU App ID 23738 TMS TMS O OH CH 3 CH 3 H N HN O O OH N H N N S N CH 3 CH 3 CH 3 OH O CH 3 CH 3 H N O OH H 3 CO CH 3 CH 3 H N O OH CH 3 CH 3 N H NH 2 AU 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min Luna ® Omega 5 Frequently Asked Questions Question 1: Are the Luna Omega stationary phases stable with a 100 % aqueous mobile phase? Question 2: How does the loadability of Luna Omega compare to other fully porous stationary phases? The Luna Omega Polar C18, Luna Omega PS C18, and Luna Omega SUGAR columns are all 100 % aqueous stable. The Luna Omega C18 requires a minimum of 5 % organic solvent in the mobile phase to prevent phase de-wetting. A thermal treatment process during the manufacturing of the Luna Omega silica particles does reduce the relative surface area of the material, however, this reduction does not negatively impact the loadability. This is because the thermal treatment reduces the presence of micropores rather than accessible particle porosity. As such Luna Omega stationary phases provides excellent loadability in comparison to other fully porous stationary phase materials. Question 3: What advantages does the Luna Omega Polar C18 phase offer when developing a method? Luna Omega Polar C18 is a reversed phase stationary phase with additional functionality that allows for retention of both non-polar and polar compounds. The phase’s unique selectivity can be used to distinguish compounds of interest that vary by polar functional groups. For example, it could provide improved separation between related compounds such as a parent drug and its polar metabolites. In addition, the column is also 100 % aqueous stable which allows for use of a wider range of mobile phases during method development. Question 4: What advantages does the Luna Omega PS C18 phase offer when developing a method? The Luna Omega PS C18 has a useful selectivity that comes from its positive surface modification and hydrophobic selectivity of a typical C18 phase. Therefore, this allows for both non-polar and polar reversed phase selectivity and increased retention. In particular the positive charge on the surface can be advantageous for method development by: Increasing reversed phase retention of small, polar basic compounds which could elute in or close to the void volume of a traditional column. Improving the peak shape of basic compounds which typically can exhibit peak tail on a traditional C18 phase. Better Peak Shape Over All Loads Aqueous Stability of Luna Omega Polar C18 Comparative separations may not be representative of all applications. 100 % Aqueous Conditions Increase Retention and Selectivity of Polar Analytes Duration of Exposure Waters ® ACQUITY ® BEH 1.7 μm C18 Amitriptyline Loading Study Luna Omega 1.6 µm PS C18 Day 1 Day 25 Dipeptides in 100 % Aqueous Conditions Competitor 1.7 µm C18 Luna Omega 1.6 µm Polar C18 % of Initial Retention Time Conditions for all columns: Columns: Luna Omega 1.6 μm PS C18 ACQUITY BEH 1.7 μm C18 Dimensions: 50 x 2.1 mm Mobile Phase: A: Water with 0.1 % Formic Acid B: Acetonitrile with 0.1 % Formic Acid Gradient: Time (min) 0 5 % B 5 80 Flow Rate: 0.4 mL/min Temperature: 22 °C Detection: UV @ 254 nm Sample: 1. Amitriptyline (0.02 µg) 2. Amitriptyline (0.04 µg) 3. Amitriptyline (0.06 µg) 4. Amitriptyline (0.08 µg) 5. Amitriptyline (0.10 µg) 6. Amitriptyline (0.15 µg) 7. Amitriptyline (0.20 µg) 8. Amitriptyline (0.30 µg) 9. Amitriptyline (0.40 µg) 10. Amitriptyline (0.5 µg) Columns: Luna Omega 1.6 µm Polar C18 Dimension: 50 x 2.1 mm Part No.: 00B-4748-AN Mobile Phase: 10 mM Ammonium Formate with 0.1 % Formic Acid Flow Rate: 0.4 mL/min Temperature: 25 °C Detection: UV @ 254 nm Sample: 1. Adenine 2. Guanosine-5-Monophosphate 3. Thymine Column: Luna Omega 1.6 µm Polar C18 Dimensions: 50 x 2.1 mm Part No.: 00B-4748-AN Mobile Phase: A: Water with 0.1 % TFA B: Acetonitrile with 0.1 % TFA Gradient: Time (min) % B 0 0 3 75 Flow Rate: 0.6 mL/min Injection Volume: 1 µL Temperature: 40 °C Detection: UV @ 210 nm (ambient) Sample: 1. Arg-Glu 2. Gly-Tyr 3. Trp-Gly 4. Gly-Trp 5. Pro-Trp Column: Competitor 1.7 µm C18 Dimensions: 50 x 2.1 mm Mobile Phase: A: Water with 0.1 % TFA B: Acetonitrile with 0.1 % TFA Gradient: Time (min) % B 0 3 3 75 Flow Rate: 0.6 mL/min Injection Volume: 1 µL Temperature: 40 °C Detection: UV @ 210 nm (ambient) Sample: 1. Arg-Glu 2. Gly-Tyr 3. Trp-Gly 4. Gly-Trp 5. Pro-Trp Column: Luna Omega 1.6 µm PS C18 Dimensions: 50 x 2.1 mm Part No.: 00B-4752-AN Mobile Phase: A: Water with 10 mM Ammonium Formate (pH 3.0) B: Acetonitrile Gradient: Time (min) % B 0 2 6 35 Flow Rate: 0.4 mL/min Injection Volume: 1 µL Temperature: 22 °C Detection: UV @ 280 nm Sample: 1. Pindolol 2. Timolol 3. Metoprolol 4. Labetalol 5. Propranolol USA Tel: 310-212-0555 | Canada Tel: 800-543-3681 | Puerto Rico Tel: 800-541-4752 | Email: [email protected]

Omega 5 Frequently Asked Questions...0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min AU App ID 23738 HLC TMS TMS O OH CH 3 CH 3 H N H O O OH N H N N S N CH 3 CH 3 CH 3 OH O CH

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Omega 5 Frequently Asked Questions...0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min AU App ID 23738 HLC TMS TMS O OH CH 3 CH 3 H N H O O OH N H N N S N CH 3 CH 3 CH 3 OH O CH

1

2

3

4

OMEGA

AU

0

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

1.5 2 2.5 min

App

ID 2

3737

TMSTMS

++

OMEGA

OMEGA

OMEGA

OMEGA

USP:L1

AU

AU

0

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

1.5 2 2.5 min

Adenine G-5-MP Thymine

100%110%

80%

60%

40%

20%

0% App

ID 2

3577

Comparative separations may not be representative of all applications.

Comparative separations may not be representative of all applications.

min0 1

1

2

2

3

3

4

5

4

0

200

400

600

800

1000

1200

1400

1600

1700

235860 1

1

2

2

3

3

4

4

5

min

0

250

500

750

1000

1250

1500

1750

mAU

App

ID 2

4612

App

ID 2

4613

App

ID 2

3727

3

1

2

3 4

5

3

0.00

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

1.5 2 2.5 min

AU

App

ID 2

3738

HILIC

TMSTMS

O

OH

CH3

CH3

HN

HN

O

O

OH

NH

NNS

N

CH3

CH3CH3

OH

O

CH3

CH3

HN

O

O

OH

OH

H3CO

H3CO

HCH3

CH3

CH3

CH3

NH

HN

O

OHCH3

CH3

NH

NH2

AU

0.00

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

1.5 2 2.5 min

Luna® Omega 5 Frequently Asked Questions Question 1: Are the Luna Omega stationary phases stable with a 100 % aqueous mobile phase?

Question 2: How does the loadability of Luna Omega compare to other fully porous stationary phases?

The Luna Omega Polar C18, Luna Omega PS C18, and Luna Omega SUGAR columns are all 100 % aqueous stable. The Luna Omega C18 requires a minimum of 5 % organic solvent in the mobile phase to prevent phase de-wetting.

A thermal treatment process during the manufacturing of the Luna Omega silica particles does reduce the relative surface area of the material, however, this reduction does not negatively impact the loadability. This is because the thermal treatment reduces the presence of micropores rather than accessible particle porosity. As such Luna Omega stationary phases provides excellent loadability in comparison to other fully porous stationary phase materials.

Question 3: What advantages does the Luna Omega Polar C18 phase offer when developing a method?

Luna Omega Polar C18 is a reversed phase stationary phase with additional functionality that allows for retention of both non-polar and polar compounds. The phase’s unique selectivity can be used to distinguish compounds of interest that vary by polar functional groups. For example, it could provide improved separation between related compounds such as a parent drug and its polar metabolites. In addition, the column is also 100 % aqueous stable which allows for use of a wider range of mobile phases during method development.

Question 4: What advantages does the Luna Omega PS C18 phase offer when developing a method?

The Luna Omega PS C18 has a useful selectivity that comes from its positive surface modification and hydrophobic selectivity of a typical C18 phase. Therefore, this allows for both non-polar and polar reversed phase selectivity and increased retention. In particular the positive charge on the surface can be advantageous for method development by:

• Increasing reversed phase retention of small, polar basic compounds which could elute in or close to the void volume of a traditional column.

• Improving the peak shape of basic compounds which typically can exhibit peak tail on a traditional C18 phase.

Better Peak Shape Over All Loads

Aqueous Stability of Luna Omega Polar C18

Comparative separations may not be representative of all applications.

100 % Aqueous Conditions Increase Retention and Selectivity of Polar Analytes

Duration of Exposure

Waters® ACQUITY® BEH 1.7 μm C18

Amitriptyline Loading Study

Luna Omega 1.6 µm PS C18

Day 1

Day 25

Dipeptides in 100 % Aqueous Conditions

Competitor 1.7 µm C18

Luna Omega 1.6 µm Polar C18

% o

f In

itial

Ret

entio

n T

ime

Conditions for all columns:Columns: Luna Omega 1.6 μm PS C18

ACQUITY BEH 1.7 μm C18Dimensions: 50 x 2.1 mm

Mobile Phase: A: Water with 0.1 % Formic AcidB: Acetonitrile with 0.1 % Formic Acid

Gradient: Time (min)05

% B580

Flow Rate: 0.4 mL/minTemperature: 22 °C

Detection: UV @ 254 nmSample: 1. Amitriptyline (0.02 µg)

2. Amitriptyline (0.04 µg)3. Amitriptyline (0.06 µg) 4. Amitriptyline (0.08 µg) 5. Amitriptyline (0.10 µg) 6. Amitriptyline (0.15 µg)7. Amitriptyline (0.20 µg) 8. Amitriptyline (0.30 µg) 9. Amitriptyline (0.40 µg)

10. Amitriptyline (0.5 µg)

Columns: Luna Omega 1.6 µm Polar C18Dimension: 50 x 2.1 mm

Part No.: 00B-4748-ANMobile Phase: 10 mM Ammonium Formate with 0.1 %

Formic AcidFlow Rate: 0.4 mL/min

Temperature: 25 °CDetection: UV @ 254 nm

Sample: 1. Adenine2. Guanosine-5-Monophosphate3. Thymine

Column: Luna Omega 1.6 µm Polar C18Dimensions: 50 x 2.1 mm

Part No.: 00B-4748-ANMobile Phase: A: Water with 0.1 % TFA

B: Acetonitrile with 0.1 % TFAGradient: Time (min) % B

0 03 75

Flow Rate: 0.6 mL/minInjection Volume: 1 µL

Temperature: 40 °CDetection: UV @ 210 nm (ambient)

Sample: 1. Arg-Glu 2. Gly-Tyr3. Trp-Gly4. Gly-Trp5. Pro-Trp

Column: Competitor 1.7 µm C18Dimensions: 50 x 2.1 mm

Mobile Phase: A: Water with 0.1 % TFAB: Acetonitrile with 0.1 % TFA

Gradient: Time (min) % B0 33 75

Flow Rate: 0.6 mL/minInjection Volume: 1 µL

Temperature: 40 °CDetection: UV @ 210 nm (ambient)

Sample: 1. Arg-Glu 2. Gly-Tyr3. Trp-Gly4. Gly-Trp5. Pro-Trp

Column: Luna Omega 1.6 µm PS C18Dimensions: 50 x 2.1 mm

Part No.: 00B-4752-ANMobile Phase: A: Water with 10 mM Ammonium Formate (pH 3.0)

B: Acetonitrile Gradient: Time (min) % B

0 26 35

Flow Rate: 0.4 mL/minInjection Volume: 1 µL

Temperature: 22 °CDetection: UV @ 280 nm

Sample: 1. Pindolol 2. Timolol3. Metoprolol4. Labetalol5. Propranolol

USA Tel: 310-212-0555 | Canada Tel: 800-543-3681 | Puerto Rico Tel: 800-541-4752 | Email: [email protected]

Page 2: Omega 5 Frequently Asked Questions...0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 1.5 2 2.5 min AU App ID 23738 HLC TMS TMS O OH CH 3 CH 3 H N H O O OH N H N N S N CH 3 CH 3 CH 3 OH O CH

OMEGA

OMEGA

TMSTMS

++TMSTMS

5

OMEGA

PolarPolar

TMSTMS

Luna® Omega 5 Frequently Asked Questions

Luna Omega Ordering Information

Luna Omega C18

Luna Omega PS C18Luna Omega Polar C18

5 Frequently Asked Questions About Luna Omega

HPLC/UHPLC Columns

5 Frequently Asked Questions About Luna Omega

HPLC/UHPLC Columns

Question 5: Can Luna Omega HPLC columns be used in supercritical fluid (SFC) separations?

The Luna Omega analytical columns are fully compatible with SFC mobile phase applications. However, non-polar phases like C18 are not typically the first choice for SFC separations. We recommend starting with a mixed functional phase such as Luna NH

2, Luna

Si(2), or Kinetex Biphenyl.

USP: L1

TMSTMS

PolarPolar

Luna Omega Polar C18100 % aqueous stability and enhanced selectivity/retention for polar analytes without diminishing useful non-polar retention. The C18 ligand provides general hydrophobic interactions while a polar modified particle surface provides enhanced polar compound retention.

HydrophobicitySteric Interaction

Hydrogen Bond Donating CapacityHydrogen Bond Accepting Capacity

Cation Selectivity at pH 2.8Cation Selectivity at pH 7.0

Low High

USP: L1

TMSTMS

++

Luna Omega PS C18Unique, 100 % aqueous stable phase that provides both polar and non-polar retention. The surface contains a positive charged ligand which aids in the retention of acidic compounds through ionic interactions, while the C18 ligand promotes general reversed phase hydrophobic retention. The positively charged surface also improves basic compound peak shape through ionic repulsion.

HydrophobicitySteric Interaction

Hydrogen Bond Donating CapacityHydrogen Bond Accepting Capacity

Cation Selectivity at pH 2.8Cation Selectivity at pH 7.0

Low High

USP: L1

TMSTMSLuna Omega C18Rugged and highly efficient C18 with strong focus on hydrophobic retention of non-polar and polar compounds.

HydrophobicitySteric Interaction

Hydrogen Bond Donating CapacityHydrogen Bond Accepting Capacity

Cation Selectivity at pH 2.8Cation Selectivity at pH 7.0

Low High

* pH stability under gradient conditions. pH stability is 1.5 - 10 under isocratic conditions.† 2.1 mm ID columns are pressure stable up to 1000 bar.

Material Characteristics

PhaseParticle

Sizes (µm)Pore Size

(Å)Effective Surface

Area (m²/g)Effective

Carbon Load %pH

StabilityPressure Stability

Luna Omega C18 1.6 100 260 11 1.5 - 8.5*

1,000/600† barLuna Omega Polar C18 1.6, 3, 5 100 260 9 1.5 - 8.5*

Luna Omega PS C18 1.6, 3, 5 100 260 9 1.5 - 8.5*

Phenomenex.com/luna

Terms and Conditions: Subject to Phenomenex standard terms & conditions, which may be viewed at www.phenomenex.com/TermsAndConditions. Trademarks: Luna is a registered trademark and SecurityGuard and MidBore are trademarks of Phenomenex. Waters and ACQUITY are registered trademarks of Waters Technologies Corporation. Disclaimer: Phenomenex is not affiliated with Waters Technologies Corporation. Comparative separations may not be representative of all applications. SecurityGuard is patented by Phenomenex. U.S. Patent No. 6,162,362. CAUTION: this patent only applies to the analytical-sized guard cartridge holder, and does not apply to SemiPrep, PREP or ULTRA holders, or to any cartridges. FOR RESEARCH USE ONLY. Not for use in clinical diagnostic procedures. © 2019 Phenomenex, Inc. All rights reserved.

5 µm Minibore and MidBore Columns (mm) SecurityGuard

Cartridges (mm)Phases 30 x 2.1 50 x 2.1 100 x 2.1 150 x 2.1 50 x 3.0 100 x 3.0 150 x 3.0 4 x 2.0*

/10 pkPolar C18 00A-4754-AN 00B-4754-AN 00D-4754-AN 00F-4754-AN 00B-4754-Y0 00D-4754-Y0 00F-4754-Y0 AJ0-7600PS C18 00A-4753-AN 00B-4753-AN 00D-4753-AN 00F-4753-AN 00B-4753-Y0 00D-4753-Y0 00F-4753-Y0 AJ0-7605

for ID: 2.0 - 3.0 mm

5 µm Analytical Columns (mm) SecurityGuard

Cartridges (mm)Phases 50 x 4.6 100 x 4.6 150 x 4.6 250 x 4.6 4 x 3.0*

/10 pkPolar C18 00B-4754-E0 00D-4754-E0 00F-4754-E0 00G-4754-E0 AJ0-7601PS C18 00B-4753-E0 00D-4753-E0 00F-4753-E0 00G-4753-E0 AJ0-7606

for ID: 3.2-8.0 mm‡ SecurityGuard ULTRA Cartridges require holder, Part No.: AJ0-9000

* SecurityGuard Standard Analytical Cartridges require holder, Part No.: KJ0-4282

1.6 µm Minibore Columns (mm) SecurityGuard™

ULTRA CartridgesPhases 30 x 2.1 50 x 2.1 100 x 2.1 150 x 2.1 3/pk‡

Polar C18 00A-4748-AN 00B-4748-AN 00D-4748-AN 00F-4748-AN AJ0-9505PS C18 00A-4752-AN 00B-4752-AN 00D-4752-AN 00F-4752-AN AJ0-9508C18 00A-4742-AN 00B-4742-AN 00D-4742-AN 00F-4742-AN AJ0-9502

for 2.1 mm ID

3 µm Analytical Columns (mm)SecurityGuard

Cartridges (mm)Phases 50 x 4.6 100 x 4.6 150 x 4.6 250 x 4.6 4 x 3.0*

/10 pkPolar C18 00B-4760-E0 00D-4760-E0 00F-4760-E0 00G-4760-E0 AJ0-7601PS C18 00B-4758-E0 00D-4758-E0 00F-4758-E0 00G-4758-E0 AJ0-7606

for ID: 3.2-8.0 mm

3 µm Minibore and MidBore™ Columns (mm) SecurityGuard

Cartridges (mm)Phases 30 x 2.1 50 x 2.1 100 x 2.1 150 x 2.1 50 x 3.0 100 x 3.0 150 x 3.0 4 x 2.0*

/10 pkPolar C18 00A-4760-AN 00B-4760-AN 00D-4760-AN 00F-4760-AN 00B-4760-Y0 00D-4760-Y0 00F-4760-Y0 AJ0-7600PS C18 00A-4758-AN 00B-4758-AN 00D-4758-AN 00F-4758-AN 00B-4758-Y0 00D-4758-Y0 00F-4758-Y0 AJ0-7605

for ID: 2.0-3.0 mm

1.6 μm Microbore Columns (mm)Phases 50 x 1.0 100 x 1.0 150 x 1.0Polar C18 00B-4748-A0 00D-4748-A0 00F-4748-A0C18 00B-4742-A0 00D-4742-A0 00F-4742-A0PS C18 00B-4752-A0 00D-4752-A0 -

PRSRT STD

U.S. POSTAGE

PAID

TORRANCE, CA

PERMIT NO. 185

411 Madrid AvenueTorrance, CA 90501-1430USA

PC

6565

0119

_us